Atour Investments Pty Ltd

Status: Registered
Australian Company Number: 145881232
Australian Business Number: 16145881232
Registration date: 19th August 2010
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Atour Investments Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2010-08-19 and was issued with the 145881232 ACN. Its Australian Business Number is 16145881232. Since 2010-08-19, the company is headquartered in VIC, post code 3911. Atour Investments Pty Ltd was registered for the GST on 2010-08-19, up until 2010-12-31. Atour Investments Pty Ltd has been using the Carr Family Trust trading name since 2010-08-19 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2011-07-05.


Details for ABN 16145881232

Type: Australian Private Company

ABN Status

Status From To
Active 19th August 2010 current

Main Name

Name From To
Atour Investments Pty Ltd 19th August 2010 current

Trading Names

Name From To
Carr Family Trust 19th August 2010 current

Main Location

Location From To
VIC 3911 19th August 2010 current

Goods & Services Tax (GST)

Status From To
Registered 19th August 2010 31st December 2010


Find company

VIC 3911 Location

2017 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (, and, ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.